25 XP   0   0   10

Jiangsu Nanfang Medical
Buy, Hold or Sell?

Let's analyse Jiangsu Nanfang Medical together

PenkeI guess you are interested in Jiangsu Nanfang Medical. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Jiangsu Nanfang Medical. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Jiangsu Nanfang Medical

I send you an email if I find something interesting about Jiangsu Nanfang Medical.

Quick analysis of Jiangsu Nanfang Medical (30 sec.)










What can you expect buying and holding a share of Jiangsu Nanfang Medical? (30 sec.)

How much money do you get?

How much money do you get?
¥0.01
When do you have the money?
1 year
How often do you get paid?
93.1%

What is your share worth?

Current worth
¥1.62
Expected worth in 1 year
¥1.12
How sure are you?
75.9%

+ What do you gain per year?

Total Gains per Share
¥-0.41
Return On Investment
-11.5%

For what price can you sell your share?

Current Price per Share
¥3.56
Expected price per share
¥3.21 - ¥4.53
How sure are you?
50%

1. Valuation of Jiangsu Nanfang Medical (5 min.)




Live pricePrice per Share (EOD)

¥3.56

Intrinsic Value Per Share

¥21.06 - ¥25.60

Total Value Per Share

¥22.68 - ¥27.22

2. Growth of Jiangsu Nanfang Medical (5 min.)




Is Jiangsu Nanfang Medical growing?

Current yearPrevious yearGrowGrow %
How rich?$65.4m$89.7m-$8m-9.9%

How much money is Jiangsu Nanfang Medical making?

Current yearPrevious yearGrowGrow %
Making money-$5m-$505.3k-$4.5m-90.1%
Net Profit Margin-29.0%-2.3%--

How much money comes from the company's main activities?

3. Financial Health of Jiangsu Nanfang Medical (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#113 / 169

Most Revenue
#114 / 169

Most Profit
#133 / 169

Most Efficient
#129 / 169

What can you expect buying and holding a share of Jiangsu Nanfang Medical? (5 min.)

Welcome investor! Jiangsu Nanfang Medical's management wants to use your money to grow the business. In return you get a share of Jiangsu Nanfang Medical.

What can you expect buying and holding a share of Jiangsu Nanfang Medical?

First you should know what it really means to hold a share of Jiangsu Nanfang Medical. And how you can make/lose money.

Speculation

The Price per Share of Jiangsu Nanfang Medical is ¥3.56. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Jiangsu Nanfang Medical.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Jiangsu Nanfang Medical, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥1.62. Based on the TTM, the Book Value Change Per Share is ¥-0.13 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.02 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Jiangsu Nanfang Medical.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps-0.07-2.1%-0.02-0.5%0.000.0%0.000.0%0.000.0%
Usd Book Value Change Per Share-0.07-2.1%-0.02-0.5%0.00-0.1%0.00-0.1%0.010.2%
Usd Dividend Per Share0.010.2%0.000.1%0.000.0%0.000.1%0.010.1%
Usd Total Gains Per Share-0.07-1.9%-0.01-0.4%0.00-0.1%0.000.0%0.010.4%
Usd Price Per Share0.70-0.70-0.84-0.96-0.85-
Price to Earnings Ratio-2.41--30.10-444.87-119.53-89.58-
Price-to-Total Gains Ratio-10.57-573.26-458.31-221.34-196.79-
Price to Book Ratio3.14-2.55-2.73-3.24-2.95-
Price-to-Total Gains Ratio-10.57-573.26-458.31-221.34-196.79-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.49128
Number of shares2035
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.020.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (2035 shares)-28.823.15
Gains per Year (2035 shares)-115.2612.62
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
126-141-12532-193
252-283-24064-3816
378-424-35595-5829
4105-566-470127-7742
5131-707-585159-9655
6157-848-700191-11568
7183-990-815223-13481
8209-1131-930255-15494
9235-1273-1045286-173107
10261-1414-1160318-192120

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%9.03.00.075.0%16.04.00.080.0%24.05.00.082.8%24.05.00.082.8%
Book Value Change Per Share1.03.00.025.0%6.06.00.050.0%11.09.00.055.0%17.09.03.058.6%17.09.03.058.6%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%27.00.02.093.1%27.00.02.093.1%
Total Gains per Share3.01.00.075.0%9.03.00.075.0%15.05.00.075.0%22.05.02.075.9%22.05.02.075.9%

Fundamentals of Jiangsu Nanfang Medical

About Jiangsu Nanfang Medical

Jiangsu Nanfang Medical Co., Ltd. engages in the research and development, production, and sale of transdermal products, medical adhesive tapes and bandages, first aid kits, sports protection products, protective products, and nursing products in China and internationally. The company offers transdermal products, such as plasters, dressings, and bandages; and protective equipment comprising daily protective masks, disposable medical masks, medical surgical masks, medical nitrile examination gloves, and medical examination gloves. It also provides medical wound dressings, capsicum plasters, physical therapy tapes, pain relief sleeves, rigid sports tapes, wound plaster dressings, medical eye pads, elastic stretch tapes, corn removal plasters, waterproof adhesive tapes, pain relief patches, kinesiology tapes, surgical tapes, zinc oxide adhesive plasters, and masks, as well as customized products. The company was founded in 1990 and is based in Changzhou, China.

Fundamental data was last updated by Penke on 2024-04-18 14:32:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Jiangsu Nanfang Medical.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Jiangsu Nanfang Medical earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Jiangsu Nanfang Medical to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of -119.2% means that ¥-1.19 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Jiangsu Nanfang Medical:

  • The MRQ is -119.2%. The company is making a huge loss. -2
  • The TTM is -29.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-119.2%TTM-29.0%-90.2%
TTM-29.0%YOY-2.3%-26.7%
TTM-29.0%5Y-4.5%-24.4%
5Y-4.5%10Y0.2%-4.8%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-119.2%6.2%-125.4%
TTM-29.0%6.2%-35.2%
YOY-2.3%8.0%-10.3%
5Y-4.5%7.3%-11.8%
10Y0.2%6.8%-6.6%
1.1.2. Return on Assets

Shows how efficient Jiangsu Nanfang Medical is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Jiangsu Nanfang Medical to the Medical Instruments & Supplies industry mean.
  • -12.1% Return on Assets means that Jiangsu Nanfang Medical generated ¥-0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Jiangsu Nanfang Medical:

  • The MRQ is -12.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.1%TTM-2.9%-9.2%
TTM-2.9%YOY-0.2%-2.7%
TTM-2.9%5Y-0.1%-2.8%
5Y-0.1%10Y0.4%-0.5%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.1%1.3%-13.4%
TTM-2.9%1.4%-4.3%
YOY-0.2%1.9%-2.1%
5Y-0.1%2.2%-2.3%
10Y0.4%2.0%-1.6%
1.1.3. Return on Equity

Shows how efficient Jiangsu Nanfang Medical is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Jiangsu Nanfang Medical to the Medical Instruments & Supplies industry mean.
  • -33.0% Return on Equity means Jiangsu Nanfang Medical generated ¥-0.33 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Jiangsu Nanfang Medical:

  • The MRQ is -33.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -8.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-33.0%TTM-8.0%-25.0%
TTM-8.0%YOY-0.6%-7.3%
TTM-8.0%5Y-0.9%-7.1%
5Y-0.9%10Y0.4%-1.3%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-33.0%2.6%-35.6%
TTM-8.0%2.8%-10.8%
YOY-0.6%3.7%-4.3%
5Y-0.9%3.9%-4.8%
10Y0.4%3.9%-3.5%

1.2. Operating Efficiency of Jiangsu Nanfang Medical.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Jiangsu Nanfang Medical is operating .

  • Measures how much profit Jiangsu Nanfang Medical makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Jiangsu Nanfang Medical to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Jiangsu Nanfang Medical:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.1%-0.1%
TTM0.1%YOY-0.2%+0.3%
TTM0.1%5Y4.2%-4.0%
5Y4.2%10Y2.9%+1.3%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.9%-7.9%
TTM0.1%7.6%-7.5%
YOY-0.2%10.9%-11.1%
5Y4.2%10.1%-5.9%
10Y2.9%10.5%-7.6%
1.2.2. Operating Ratio

Measures how efficient Jiangsu Nanfang Medical is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 2.44 means that the operating costs are ¥2.44 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Jiangsu Nanfang Medical:

  • The MRQ is 2.439. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.983. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.439TTM1.983+0.456
TTM1.983YOY1.889+0.094
TTM1.9835Y1.781+0.202
5Y1.78110Y1.431+0.350
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4391.153+1.286
TTM1.9831.168+0.815
YOY1.8891.105+0.784
5Y1.7811.097+0.684
10Y1.4311.056+0.375

1.3. Liquidity of Jiangsu Nanfang Medical.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Jiangsu Nanfang Medical is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 0.72 means the company has ¥0.72 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Jiangsu Nanfang Medical:

  • The MRQ is 0.719. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.804. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.719TTM0.804-0.085
TTM0.804YOY0.887-0.083
TTM0.8045Y1.345-0.541
5Y1.34510Y0.927+0.417
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7192.302-1.583
TTM0.8042.333-1.529
YOY0.8872.588-1.701
5Y1.3452.627-1.282
10Y0.9272.623-1.696
1.3.2. Quick Ratio

Measures if Jiangsu Nanfang Medical is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Jiangsu Nanfang Medical to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 0.20 means the company can pay off ¥0.20 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Jiangsu Nanfang Medical:

  • The MRQ is 0.201. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.263. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.201TTM0.263-0.061
TTM0.263YOY0.257+0.006
TTM0.2635Y0.394-0.131
5Y0.39410Y0.407-0.013
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2011.098-0.897
TTM0.2631.127-0.864
YOY0.2571.306-1.049
5Y0.3941.430-1.036
10Y0.4071.533-1.126

1.4. Solvency of Jiangsu Nanfang Medical.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Jiangsu Nanfang Medical assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Jiangsu Nanfang Medical to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.63 means that Jiangsu Nanfang Medical assets are financed with 62.9% credit (debt) and the remaining percentage (100% - 62.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Jiangsu Nanfang Medical:

  • The MRQ is 0.629. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.582. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.629TTM0.582+0.046
TTM0.582YOY0.538+0.044
TTM0.5825Y0.450+0.132
5Y0.45010Y0.413+0.037
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6290.357+0.272
TTM0.5820.360+0.222
YOY0.5380.353+0.185
5Y0.4500.365+0.085
10Y0.4130.371+0.042
1.4.2. Debt to Equity Ratio

Measures if Jiangsu Nanfang Medical is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Jiangsu Nanfang Medical to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 171.1% means that company has ¥1.71 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Jiangsu Nanfang Medical:

  • The MRQ is 1.711. The company is just able to pay all its debts with equity.
  • The TTM is 1.418. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.711TTM1.418+0.293
TTM1.418YOY1.183+0.235
TTM1.4185Y0.893+0.525
5Y0.89310Y0.788+0.105
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7110.541+1.170
TTM1.4180.561+0.857
YOY1.1830.551+0.632
5Y0.8930.653+0.240
10Y0.7880.669+0.119

2. Market Valuation of Jiangsu Nanfang Medical

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Jiangsu Nanfang Medical generates.

  • Above 15 is considered overpriced but always compare Jiangsu Nanfang Medical to the Medical Instruments & Supplies industry mean.
  • A PE ratio of -2.41 means the investor is paying ¥-2.41 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Jiangsu Nanfang Medical:

  • The EOD is -1.683. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.406. Based on the earnings, the company is expensive. -2
  • The TTM is -30.098. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.683MRQ-2.406+0.723
MRQ-2.406TTM-30.098+27.692
TTM-30.098YOY444.875-474.973
TTM-30.0985Y119.531-149.630
5Y119.53110Y89.582+29.949
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-1.68314.408-16.091
MRQ-2.40615.934-18.340
TTM-30.09816.376-46.474
YOY444.87522.147+422.728
5Y119.53120.830+98.701
10Y89.58225.069+64.513
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Jiangsu Nanfang Medical:

  • The EOD is 2.859. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 4.087. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -88.757. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD2.859MRQ4.087-1.229
MRQ4.087TTM-88.757+92.845
TTM-88.757YOY3.961-92.718
TTM-88.7575Y-18.011-70.746
5Y-18.01110Y-16.805-1.206
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD2.8599.511-6.652
MRQ4.0879.241-5.154
TTM-88.7570.922-89.679
YOY3.9613.453+0.508
5Y-18.0115.897-23.908
10Y-16.805-0.177-16.628
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Jiangsu Nanfang Medical is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 3.14 means the investor is paying ¥3.14 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Jiangsu Nanfang Medical:

  • The EOD is 2.196. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.139. Based on the equity, the company is fair priced.
  • The TTM is 2.549. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.196MRQ3.139-0.944
MRQ3.139TTM2.549+0.590
TTM2.549YOY2.733-0.183
TTM2.5495Y3.242-0.692
5Y3.24210Y2.946+0.296
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD2.1962.448-0.252
MRQ3.1392.753+0.386
TTM2.5492.691-0.142
YOY2.7333.294-0.561
5Y3.2423.563-0.321
10Y2.9464.227-1.281
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Jiangsu Nanfang Medical compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.529-0.126-76%-0.029-95%-0.017-97%0.056-1046%
Book Value Per Share--1.6212.023-20%2.223-27%2.148-25%1.935-16%
Current Ratio--0.7190.804-11%0.887-19%1.345-47%0.927-22%
Debt To Asset Ratio--0.6290.582+8%0.538+17%0.450+40%0.413+52%
Debt To Equity Ratio--1.7111.418+21%1.183+45%0.893+92%0.788+117%
Dividend Per Share--0.0470.023+103%0.010+371%0.028+67%0.039+22%
Eps---0.529-0.126-76%0.013-4247%-0.005-99%0.008-6558%
Free Cash Flow Per Share--0.311-0.043+114%-0.098+132%-0.078+125%-0.046+115%
Free Cash Flow To Equity Per Share--0.311-0.050+116%0.050+523%-0.015+105%0.052+500%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.966+4%
Intrinsic Value_10Y_max--25.603--------
Intrinsic Value_10Y_min--21.057--------
Intrinsic Value_1Y_max---0.078--------
Intrinsic Value_1Y_min---0.079--------
Intrinsic Value_3Y_max--1.780--------
Intrinsic Value_3Y_min--1.658--------
Intrinsic Value_5Y_max--6.067--------
Intrinsic Value_5Y_min--5.458--------
Market Cap1041207383.040-43%1488692660.0001485767920.000+0%1774585995.000-16%2038516725.339-27%1796163998.834-17%
Net Profit Margin---1.192-0.290-76%-0.023-98%-0.045-96%0.002-50932%
Operating Margin---0.001-100%-0.0020%0.042-100%0.029-100%
Operating Ratio--2.4391.983+23%1.889+29%1.781+37%1.431+70%
Pb Ratio2.196-43%3.1392.549+23%2.733+15%3.242-3%2.946+7%
Pe Ratio-1.683+30%-2.406-30.098+1151%444.875-101%119.531-102%89.582-103%
Price Per Share3.560-43%5.0905.080+0%6.068-16%6.969-27%6.140-17%
Price To Free Cash Flow Ratio2.859-43%4.087-88.757+2271%3.961+3%-18.011+541%-16.805+511%
Price To Total Gains Ratio-7.391+30%-10.567573.258-102%458.315-102%221.343-105%196.793-105%
Quick Ratio--0.2010.263-23%0.257-22%0.394-49%0.407-51%
Return On Assets---0.121-0.029-76%-0.002-98%-0.001-99%0.004-2985%
Return On Equity---0.330-0.080-76%-0.006-98%-0.009-97%0.004-8094%
Total Gains Per Share---0.482-0.103-79%-0.019-96%0.011-4388%0.094-610%
Usd Book Value--65442296.05181648976.515-20%89733362.147-27%86731889.774-25%78099619.106-16%
Usd Book Value Change Per Share---0.073-0.017-76%-0.004-95%-0.002-97%0.008-1046%
Usd Book Value Per Share--0.2240.279-20%0.307-27%0.296-25%0.267-16%
Usd Dividend Per Share--0.0070.003+103%0.001+371%0.004+67%0.005+22%
Usd Eps---0.073-0.017-76%0.002-4247%-0.001-99%0.001-6558%
Usd Free Cash Flow--12565434.738-1747427.997+114%-3963352.360+132%-3133106.333+125%-1807569.967+114%
Usd Free Cash Flow Per Share--0.043-0.006+114%-0.014+132%-0.011+125%-0.006+115%
Usd Free Cash Flow To Equity Per Share--0.043-0.007+116%0.007+523%-0.002+105%0.007+500%
Usd Market Cap143686618.860-43%205439587.080205035972.960+0%244892867.310-16%281315308.097-27%247870631.839-17%
Usd Price Per Share0.491-43%0.7020.701+0%0.837-16%0.962-27%0.847-17%
Usd Profit---21345823.365-5085895.690-76%-505380.236-98%-405090.497-98%253007.926-8537%
Usd Revenue--17910446.50020703289.357-13%18815235.731-5%22335252.298-20%19825469.667-10%
Usd Total Gains Per Share---0.066-0.014-79%-0.003-96%0.002-4388%0.013-610%
 EOD+4 -4MRQTTM+10 -25YOY+9 -255Y+10 -2510Y+10 -26

3.2. Fundamental Score

Let's check the fundamental score of Jiangsu Nanfang Medical based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.683
Price to Book Ratio (EOD)Between0-12.196
Net Profit Margin (MRQ)Greater than0-1.192
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.201
Current Ratio (MRQ)Greater than10.719
Debt to Asset Ratio (MRQ)Less than10.629
Debt to Equity Ratio (MRQ)Less than11.711
Return on Equity (MRQ)Greater than0.15-0.330
Return on Assets (MRQ)Greater than0.05-0.121
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Jiangsu Nanfang Medical based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.334
Ma 20Greater thanMa 503.772
Ma 50Greater thanMa 1003.866
Ma 100Greater thanMa 2004.393
OpenGreater thanClose3.490
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Gross Profit  6,76919,97226,7411,94128,681-12,06716,614-32,984-16,370



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets1,277,326
Total Liabilities803,107
Total Stockholder Equity469,268
 As reported
Total Liabilities 803,107
Total Stockholder Equity+ 469,268
Total Assets = 1,277,326

Assets

Total Assets1,277,326
Total Current Assets569,536
Long-term Assets707,790
Total Current Assets
Cash And Cash Equivalents 95,673
Short-term Investments 22,523
Net Receivables 136,965
Inventory 267,580
Other Current Assets 8,573
Total Current Assets  (as reported)569,536
Total Current Assets  (calculated)531,314
+/- 38,222
Long-term Assets
Property Plant Equipment 557,571
Intangible Assets 39,642
Long-term Assets Other 4,799
Long-term Assets  (as reported)707,790
Long-term Assets  (calculated)602,011
+/- 105,779

Liabilities & Shareholders' Equity

Total Current Liabilities791,922
Long-term Liabilities11,185
Total Stockholder Equity469,268
Total Current Liabilities
Short Long Term Debt 452,034
Accounts payable 215,412
Other Current Liabilities 69,598
Total Current Liabilities  (as reported)791,922
Total Current Liabilities  (calculated)737,043
+/- 54,879
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt418
Long-term Liabilities  (as reported)11,185
Long-term Liabilities  (calculated)418
+/- 10,767
Total Stockholder Equity
Retained Earnings 32,441
Total Stockholder Equity (as reported)469,268
Total Stockholder Equity (calculated)32,441
+/- 436,827
Other
Capital Stock292,474
Common Stock Shares Outstanding 292,474
Net Debt 356,361
Net Invested Capital 921,302
Net Working Capital -222,386
Property Plant and Equipment Gross 557,571



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-03-312016-12-312016-03-312015-12-312014-12-31
> Total Assets 
437,008
473,369
0
516,552
0
799,174
822,965
800,291
843,419
842,850
0
851,964
831,102
802,378
869,602
898,068
1,087,433
1,092,792
1,072,645
1,127,518
1,216,831
1,260,949
1,235,191
1,329,432
1,377,466
1,484,482
1,457,234
1,490,103
1,408,620
1,474,821
1,277,326
1,277,3261,474,8211,408,6201,490,1031,457,2341,484,4821,377,4661,329,4321,235,1911,260,9491,216,8311,127,5181,072,6451,092,7921,087,433898,068869,602802,378831,102851,9640842,850843,419800,291822,965799,1740516,5520473,369437,008
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
603,726
569,347
478,617
501,454
526,527
714,036
705,020
644,235
661,999
653,719
599,342
587,891
585,505
642,680
713,122
678,345
704,893
633,760
670,589
569,536
569,536670,589633,760704,893678,345713,122642,680585,505587,891599,342653,719661,999644,235705,020714,036526,527501,454478,617569,347603,72600000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
292,752
190,759
89,301
193,666
183,453
294,620
325,574
325,210
279,576
280,452
197,240
152,815
105,888
140,201
162,518
127,818
147,126
78,266
95,823
95,673
95,67395,82378,266147,126127,818162,518140,201105,888152,815197,240280,452279,576325,210325,574294,620183,453193,66689,301190,759292,75200000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
40,000
50,000
110,000
80,000
0
30,000
0
0
20,000
20,000
20,000
20,000
21,226
21,226
21,226
21,226
22,523
22,52321,22621,22621,22621,22620,00020,00020,00020,0000030,000080,000110,00050,00040,00000000000000000
       Net Receivables 
190,057
189,015
0
146,586
0
141,968
148,397
155,733
211,016
214,061
0
126,901
136,606
130,103
144,710
113,089
157,653
136,448
161,352
164,524
174,052
199,788
153,108
172,169
178,297
188,396
131,635
207,672
223,415
185,375
136,965
136,965185,375223,415207,672131,635188,396178,297172,169153,108199,788174,052164,524161,352136,448157,653113,089144,710130,103136,606126,9010214,061211,016155,733148,397141,9680146,5860189,015190,057
       Other Current Assets 
2,060
3,839
0
8,439
0
87,510
5,178
89,733
6,067
64,712
0
31,688
55,670
110,838
4,501
46,916
31,321
35,364
39,297
40,106
46,111
35,863
45,154
38,333
10,810
22,355
4,840
33,692
26,272
9,983
8,573
8,5739,98326,27233,6924,84022,35510,81038,33345,15435,86346,11140,10639,29735,36431,32146,9164,501110,83855,67031,688064,7126,06789,7335,17887,51008,43903,8392,060
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
248,238
261,755
323,761
368,148
371,541
373,397
387,772
428,410
465,519
563,113
661,606
647,299
743,927
734,786
771,360
778,889
785,210
774,860
804,232
707,790
707,790804,232774,860785,210778,889771,360734,786743,927647,299661,606563,113465,519428,410387,772373,397371,541368,148323,761261,755248,23800000000000
       Property Plant Equipment 
60,963
56,893
0
96,461
0
104,649
127,400
127,322
126,628
130,407
159,771
170,348
170,944
180,955
260,864
256,945
264,697
281,215
299,836
304,371
429,706
380,477
518,733
526,175
599,368
640,934
632,161
627,171
623,568
633,023
557,571
557,571633,023623,568627,171632,161640,934599,368526,175518,733380,477429,706304,371299,836281,215264,697256,945260,864180,955170,944170,348159,771130,407126,628127,322127,400104,649096,461056,89360,963
       Goodwill 
0
0
0
0
0
8,029
8,029
8,029
8,029
8,029
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000008,0298,0298,0298,0298,02900000
       Intangible Assets 
31,944
46,078
0
52,172
0
59,346
59,104
58,805
36,468
36,291
0
27,910
13
27,561
27,386
27,218
27,050
26,882
36,714
36,834
36,614
36,395
36,175
35,956
40,862
40,617
40,371
40,126
39,881
39,636
39,642
39,64239,63639,88140,12640,37140,61740,86235,95636,17536,39536,61436,83436,71426,88227,05027,21827,38627,5611327,910036,29136,46858,80559,10459,346052,172046,07831,944
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
39,933
53,894
106,357
67,224
22,503
15,239
290,406
16,491
47,196
20,041
172,957
1,374
89,861
1,522
1,242
2,229
2,229
5,283
30,136
4,799
4,79930,1365,2832,2292,2291,2421,52289,8611,374172,95720,04147,19616,491290,40615,23922,50367,224106,35753,89439,93300000000000
> Total Liabilities 
226,104
250,858
0
259,867
0
267,257
285,396
250,573
282,113
268,590
0
282,513
269,161
226,801
302,079
320,811
444,438
440,643
371,841
412,245
526,360
567,053
580,294
674,228
715,731
821,937
835,751
856,042
779,177
845,907
803,107
803,107845,907779,177856,042835,751821,937715,731674,228580,294567,053526,360412,245371,841440,643444,438320,811302,079226,801269,161282,5130268,590282,113250,573285,396267,2570259,8670250,858226,104
   > Total Current Liabilities 
225,279
250,135
0
249,671
0
257,138
275,302
240,505
272,338
258,829
0
272,778
259,440
217,093
292,464
311,325
435,089
431,428
359,475
400,013
514,401
555,298
566,457
660,707
702,285
786,679
807,700
827,951
758,112
828,214
791,922
791,922828,214758,112827,951807,700786,679702,285660,707566,457555,298514,401400,013359,475431,428435,089311,325292,464217,093259,440272,7780258,829272,338240,505275,302257,1380249,6710250,135225,279
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
151,000
141,000
122,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000122,000141,000151,00000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
151,000
141,000
122,000
142,000
156,000
171,000
241,000
177,625
234,942
321,796
341,318
352,230
443,615
437,176
484,712
430,869
478,484
436,885
512,824
452,034
452,034512,824436,885478,484430,869484,712437,176443,615352,230341,318321,796234,942177,625241,000171,000156,000142,000122,000141,000151,00000000000000
       Accounts payable 
43,334
49,038
0
63,884
0
85,908
98,743
90,152
96,735
83,546
0
106,244
102,578
73,336
130,304
120,205
186,720
149,079
115,011
125,108
141,486
155,800
170,856
175,956
221,387
253,203
278,029
266,245
240,800
248,175
215,412
215,412248,175240,800266,245278,029253,203221,387175,956170,856155,800141,486125,108115,011149,079186,720120,205130,30473,336102,578106,244083,54696,73590,15298,74385,908063,884049,03843,334
       Other Current Liabilities 
25,945
27,098
0
32,788
0
15,230
20,559
14,353
19,603
19,282
0
0
0
14,364
7,763
29,805
61,631
28,129
49,000
31,505
39,638
46,951
31,298
31,006
30,867
35,892
31,026
28,191
48,700
14,363
69,598
69,59814,36348,70028,19131,02635,89230,86731,00631,29846,95139,63831,50549,00028,12961,63129,8057,76314,36400019,28219,60314,35320,55915,230032,788027,09825,945
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
9,735
9,721
9,708
9,615
9,486
9,349
9,216
12,366
12,233
11,958
11,755
13,837
13,521
13,446
35,257
28,051
28,090
21,064
17,693
11,185
11,18517,69321,06428,09028,05135,25713,44613,52113,83711,75511,95812,23312,3669,2169,3499,4869,6159,7089,7219,73500000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
-151,000
-141,000
-122,000
0
0
0
0
0
0
0
0
1,453
1,358
1,490
1,508
638
884
903
489
418
4184899038846381,5081,4901,3581,45300000000-122,000-141,000-151,00000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
900
900
900
900
0
0
0
0
0
000009009009009000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
5,417
5,747
4,926
4,541
5,776
4,742
4,472
6,543
3,647
3,350
3,001
2,687
9,065
8,695
7,803
7,199
0
9,369
5,872
0
0
005,8729,36907,1997,8038,6959,0652,6873,0013,3503,6476,5434,4724,7425,7764,5414,9265,7475,4170000000000
> Total Stockholder Equity
209,462
220,840
222,510
252,959
256,685
525,330
531,814
544,018
555,759
569,819
0
566,027
559,005
569,136
564,157
572,753
638,086
646,764
696,791
711,406
685,204
688,727
649,785
650,745
656,871
657,774
616,660
630,584
624,560
623,923
469,268
469,268623,923624,560630,584616,660657,774656,871650,745649,785688,727685,204711,406696,791646,764638,086572,753564,157569,136559,005566,0270569,819555,759544,018531,814525,330256,685252,959222,510220,840209,462
   Common Stock
75,000
75,000
0
75,000
0
100,000
100,000
100,000
130,000
130,000
130,000
130,000
169,000
169,000
169,000
169,000
219,700
219,700
225,180
225,180
292,734
292,734
292,474
292,474
292,474
292,474
0
292,474
292,474
0
0
00292,474292,4740292,474292,474292,474292,474292,734292,734225,180225,180219,700219,700169,000169,000169,000169,000130,000130,000130,000130,000100,000100,000100,000075,000075,00075,000
   Retained Earnings 
105,445
116,688
0
148,668
0
164,785
171,270
183,474
195,215
209,275
196,020
175,138
168,115
178,246
203,271
212,704
278,037
286,716
292,889
302,017
270,328
273,851
236,350
237,311
243,437
244,339
179,858
235,625
229,602
187,121
32,441
32,441187,121229,602235,625179,858244,339243,437237,311236,350273,851270,328302,017292,889286,716278,037212,704203,271178,246168,115175,138196,020209,275195,215183,474171,270164,7850148,6680116,688105,445
   Capital Surplus 0000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
161
161
161
161
342
342
342
342
244
244
244
244
212
212
212
212
0
338
338
0
0
0033833802122122122122442442442443423423423421611611611610000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue600,095
Cost of Revenue-544,429
Gross Profit55,66655,666
 
Operating Income (+$)
Gross Profit55,666
Operating Expense-636,569
Operating Income-36,473-580,903
 
Operating Expense (+$)
Research Development28,181
Selling General Administrative25,738
Selling And Marketing Expenses0
Operating Expense636,56953,920
 
Net Interest Income (+$)
Interest Income1,156
Interest Expense-23,188
Other Finance Cost-316
Net Interest Income-22,347
 
Pretax Income (+$)
Operating Income-36,473
Net Interest Income-22,347
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-148,519-36,473
EBIT - interestExpense = -23,188
-147,417
-124,229
Interest Expense23,188
Earnings Before Interest and Taxes (EBIT)0-125,331
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-148,519
Tax Provision--1,230
Net Income From Continuing Ops-147,289-147,289
Net Income-147,417
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net022,347
 

Technical Analysis of Jiangsu Nanfang Medical
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Jiangsu Nanfang Medical. The general trend of Jiangsu Nanfang Medical is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Jiangsu Nanfang Medical's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Jiangsu Nanfang Medical.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3.94 < 3.94 < 4.53.

The bearish price targets are: 3.35 > 3.21.

Tweet this
Jiangsu Nanfang Medical Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Jiangsu Nanfang Medical. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Jiangsu Nanfang Medical Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Jiangsu Nanfang Medical. The current macd is -0.16214083.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Jiangsu Nanfang Medical price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Jiangsu Nanfang Medical. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Jiangsu Nanfang Medical price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Jiangsu Nanfang Medical Daily Moving Average Convergence/Divergence (MACD) ChartJiangsu Nanfang Medical Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Jiangsu Nanfang Medical. The current adx is 25.81.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Jiangsu Nanfang Medical shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Jiangsu Nanfang Medical Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Jiangsu Nanfang Medical. The current sar is 3.35.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Jiangsu Nanfang Medical Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Jiangsu Nanfang Medical. The current rsi is 37.33. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Jiangsu Nanfang Medical Daily Relative Strength Index (RSI) ChartJiangsu Nanfang Medical Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Jiangsu Nanfang Medical. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Jiangsu Nanfang Medical price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Jiangsu Nanfang Medical Daily Stochastic Oscillator ChartJiangsu Nanfang Medical Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Jiangsu Nanfang Medical. The current cci is -66.22835854.

Jiangsu Nanfang Medical Daily Commodity Channel Index (CCI) ChartJiangsu Nanfang Medical Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Jiangsu Nanfang Medical. The current cmo is -25.17640582.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Jiangsu Nanfang Medical Daily Chande Momentum Oscillator (CMO) ChartJiangsu Nanfang Medical Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Jiangsu Nanfang Medical. The current willr is -70.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Jiangsu Nanfang Medical is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Jiangsu Nanfang Medical Daily Williams %R ChartJiangsu Nanfang Medical Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Jiangsu Nanfang Medical.

Jiangsu Nanfang Medical Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Jiangsu Nanfang Medical. The current atr is 0.13786472.

Jiangsu Nanfang Medical Daily Average True Range (ATR) ChartJiangsu Nanfang Medical Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Jiangsu Nanfang Medical. The current obv is 136,554,441.

Jiangsu Nanfang Medical Daily On-Balance Volume (OBV) ChartJiangsu Nanfang Medical Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Jiangsu Nanfang Medical. The current mfi is 28.87.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Jiangsu Nanfang Medical Daily Money Flow Index (MFI) ChartJiangsu Nanfang Medical Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Jiangsu Nanfang Medical.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-31ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-07ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-19MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-28ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-06ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-24MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-25MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.

6.3. Candlestick Patterns

Jiangsu Nanfang Medical Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Jiangsu Nanfang Medical based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.334
Ma 20Greater thanMa 503.772
Ma 50Greater thanMa 1003.866
Ma 100Greater thanMa 2004.393
OpenGreater thanClose3.490
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Jiangsu Nanfang Medical with someone you think should read this too:
  • Are you bullish or bearish on Jiangsu Nanfang Medical? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Jiangsu Nanfang Medical? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Jiangsu Nanfang Medical

I send you an email if I find something interesting about Jiangsu Nanfang Medical.


Comments

How you think about this?

Leave a comment

Stay informed about Jiangsu Nanfang Medical.

Receive notifications about Jiangsu Nanfang Medical in your mailbox!